Many antibiotic prescriptions in the United States in recent years may not have been appropriate, a recent study found.

Behavior therapy may be an underused form of treatment for children with attention deficit hyperactivity disorder (ADHD), according to the Centers for Disease Control and Prevention (CDC).

Post-surgery survival rates for older patients with lung cancer may be improving, a new study found.

For babies younger than 6 months, influenza vaccination has not been proven to be successful. But a new study found a different way to protect babies from the flu.

Before anti-VEGF medications like Avastin (bevacizumab) and Lucentis (ranibizumab), patients with age-related macular degeneration (AMD) had much worse outcomes, a new study found.

The US Food and Drug Administration (FDA) has approved a new medication to treat chronic obstructive pulmonary disease (COPD).

The US Food and Drug Administration (FDA) has approved a new opioid with abuse-deterrent properties.

Countless studies have evaluated specific interventions to manage weight. But a new study may have found an intervention that will effectively prevent weight gain.

The first generic version of Crestor (rosuvastatin) has received approval from the US Food and Drug Administration (FDA).

The US Food and Drug Administration (FDA) has approved Nuplazid (pimavanserin) tablets to treat hallucinations and delusions in patients with Parkinson's disease.